Prolia for Bone Fractures — I’m Nonetheless Not Impressed

[ad_1] When the bone drug Prolia (denosumab) first got here out in 2010, I took a tough have a look at it as a result of it used a very completely different mechanism than broadly used bisphosphonate medication, specializing in the RANK/RANK-L/OPG system to stop osteoclasts from being “activated” as an alternative of reducing their … Read more

The Real Risk Behind Fractures: Why Fall Prevention Matters More Than You Think

[ad_1] Let’s talk about falls and fractures. A recent study of over 3,000 veterans caught my eye—and it made me rethink how we approach fracture risk altogether. For years, the medical field has focused almost exclusively on bone density and bone drugs. But this study suggests we might be in the wrong lane. We need … Read more